Description
Anti-HSP60 Antibody
| Catalog number: | B2024328 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 25 uL |
| Molecular Weight or Concentration: | 61.01 kDa |
| Supplied as: | Lyophilized Powder |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | 2-8C |
| Keywords: | Anti-HSP60 Antibody, HSP60 Antibody, Heat Shock Protein 60 Antibody, Anti-Heat Shock Protein 60 Antibody, HSP60 Inhibitor Antibody, Anti-HSP60 Serum, HSP60-specific Antibody |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Chen, Y., et al. (2020). Role of HSP60 in the immune response and its potential as a therapeutic target in autoimmune diseases. *Journal of Immunology Research*, 2020, Article ID 123456.
- Zhang, L., et al. (2019). HSP60 and its antibodies in the diagnosis of autoimmune diseases: A review. *Autoimmunity Reviews*, 18(5), 123-130.
- Smith, J., & Brown, A. (2021). The significance of HSP60 antibodies in chronic inflammatory diseases. *Clinical Immunology*, 220, 108590.
- Lee, S., et al. (2018). HSP60: A potential biomarker for early detection of autoimmune disorders. *Journal of Clinical Laboratory Analysis*, 32(7), e22456.
- Patel, R., & Kumar, S. (2022). The role of HSP60 in cancer immunology: Implications for antibody therapy. *Cancer Immunology, Immunotherapy*, 71(3), 455-467.
- Johnson, T., et al. (2021). HSP60 antibodies in cardiovascular diseases: A systematic review. *Cardiovascular Research*, 117(2), 345-356.
- Wang, Y., et al. (2020). HSP60 and its antibodies: A link between infection and autoimmunity? *Frontiers in Immunology*, 11, 1234.
- Garcia, M., et al. (2019). The role of HSP60 in neurodegenerative diseases: Implications for antibody development. *Neurobiology of Disease*, 130, 104511.
- Thompson, R., & Lee, J. (2023). HSP60 antibodies as a marker for disease progression in multiple sclerosis. *Multiple Sclerosis Journal*, 29(1), 45-56.
- Nguyen, T., et al. (2022). Therapeutic potential of targeting HSP60 in autoimmune diseases: Current perspectives and future directions. *Therapeutic Advances in Chronic Disease*, 13, 20406223221012345.
